Search
From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Weight loss drug hope for patients with type 2 diabetes
Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10 kg, according to a new study published in The Lancet.
Over 780 COVID patients hospitalized in 24 hours: Ministry
The number of coronavirus patients who were admitted to hospitals across Iran over the 24-hour period, to Tuesday noon, stood at 784, the Health Ministry announced.
Study: Hepatitis drug speeds recovery in non-hospitalized COVID-19 patients
A single injection of an experimental antiviral drug appears to speed recovery times in non-hospitalized patients with COVID-19, according to a study published Friday by Lancet Respiratory Medicine.
Warning over ‘influx’ of seriously ill cancer patients after pandemic in Ireland
The health service in Ireland needs to prepare for an “influx” of seriously ill cancer patients once the COVID-19 pandemic nears its end, an oncologist has warned.
Ministry: Nearly 1.2m coronavirus patients have recovered so far
More than 1,170,000 coronavirus positive cases have recovered from the infectious disease in Iran, the Health Ministry said on Monday.
Rapid blood test identifies COVID-19 patients at high risk of severe disease
One of the most vexing aspects of the COVID-19 pandemic is doctors' inability to predict which newly hospitalized patients will go on to develop severe disease, including complications that require the insertion of a breathing tube, kidney dialysis or other intensive care. Knowledge of a patient's age and underlying medical conditions can help predict such outcomes, but there are still surprises when younger, seemingly healthier patients suffer severe complications that can lead to death.
Most COVID-19 patients have at least one symptom six months on: Study
More than three quarters of people hospitalized with COVID-19 still suffered from at least one symptom after six months, according to a study published on Saturday that scientists said shows the need for further investigation into lingering coronavirus effects.
Inflammation from ADT may cause fatigue in prostate cancer patients
Prostate cancer is one of the most common cancers among men in the US. For many patients, hormone therapy is a treatment option. This type of therapy, also called androgen deprivation therapy (ADT), reduces the level of testosterone and other androgens in the body. Lowering androgen levels can make prostate cancer cells grow more slowly or shrink tumors over time. However, patients receiving ADT often experience higher levels of fatigue, depression and cognitive impairment.
US doctor says beds open up only when patients die
With the number of COVID-19 hospitalizations at an all-time high in the US, medical facilities are having a hard time finding places to put new patients.
Small number of COVID patients develop severe psychotic symptoms
Almost immediately, Dr. Hisam Goueli could tell that the patient who came to his psychiatric hospital on Long Island this summer was unusual.
Most kidney patients ok with getting text reminders on care
Adults living with kidney failure are receptive to using mobile devices to help with their care, according to a new study.
First 10 days after leaving hospital carry high risk for COVID-19 patients: Study
In the first months after their COVID-19 hospital stay, patients face a high risk of ongoing health problems, trips back to the hospital, and death, a growing number of studies has shown.
Patients with noncardiac chest pain are reassured with brief education
Patients diagnosed with noncardiac chest pain are reluctant to believe they do not have heart disease. A new study shows that explaining the test results convinces patients and reduces the likelihood of future chest pain. The research is presented at EACVI—Best of Imaging 2020, a scientific congress of the European Society of Cardiology (ESC).
Chronic disease patients can't slack post virus: Expert
People with chronic illnesses who recover from COVID-19 must remain wary of its enduring effects on their bodies, a Turkish doctor warned.
Plasma from recovered patients shows little benefit in those hospitalized with COVID-19: Study
Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released from a clinical trial in Argentina.

Page Generated in 2/5453 sec